Bright Minds Biosciences Stock Fundamentals
| DRUG Stock | USD 34.03 0.00 0.00% |
Bright Minds Biosciences fundamentals help investors to digest information that contributes to Bright Minds' financial success or failures. It also enables traders to predict the movement of Bright Stock. The fundamental analysis module provides a way to measure Bright Minds' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bright Minds stock.
At this time, Bright Minds' Reconciled Depreciation is most likely to increase significantly in the upcoming years. Bright | Select Account or Indicator |
Bright Minds Biosciences Company Shares Outstanding Analysis
Bright Minds' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Bright Minds Shares Outstanding | 6.99 M |
Most of Bright Minds' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bright Minds Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Bright Shares Outstanding Historical Pattern
Today, most investors in Bright Minds Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Bright Minds' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's shares outstanding growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Bright Minds shares outstanding as a starting point in their analysis.
Bright Minds Shares Outstanding |
| Timeline |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Bright Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Based on the latest financial disclosure, Bright Minds Biosciences has 6.99 M of shares currently outstending. This is 96.13% lower than that of the Biotechnology sector and 93.46% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 98.78% higher than that of the company.
Bright Minds Biosciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Bright Minds's current stock value. Our valuation model uses many indicators to compare Bright Minds value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bright Minds competition to find correlations between indicators driving Bright Minds's intrinsic value. More Info.Bright Minds Biosciences is rated # 3 in return on equity category among its peers. It is rated # 5 in return on asset category among its peers . At this time, Bright Minds' Return On Equity is most likely to slightly decrease in the upcoming years. Comparative valuation analysis is a catch-all technique that is used if you cannot value Bright Minds by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Bright Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bright Minds' direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bright Minds could also be used in its relative valuation, which is a method of valuing Bright Minds by comparing valuation metrics of similar companies.Bright Minds is currently under evaluation in shares outstanding category among its peers.
Bright Minds ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Bright Minds' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Bright Minds' managers, analysts, and investors.Environmental | Governance | Social |
Bright Fundamentals
| Return On Equity | -0.52 | ||||
| Return On Asset | -0.29 | ||||
| Current Valuation | 212.51 M | ||||
| Shares Outstanding | 6.99 M | ||||
| Shares Owned By Insiders | 27.28 % | ||||
| Shares Owned By Institutions | 44.27 % | ||||
| Number Of Shares Shorted | 137.7 K | ||||
| Price To Book | 6.24 X | ||||
| EBITDA | (7.28 M) | ||||
| Net Income | (2.8 M) | ||||
| Cash And Equivalents | 8.64 M | ||||
| Cash Per Share | 0.71 X | ||||
| Total Debt | 118.96 K | ||||
| Current Ratio | 22.88 X | ||||
| Book Value Per Share | 1.37 X | ||||
| Cash Flow From Operations | (1.85 M) | ||||
| Short Ratio | 1.24 X | ||||
| Earnings Per Share | (0.45) X | ||||
| Target Price | 92.32 | ||||
| Beta | 1.13 | ||||
| Market Capitalization | 226.37 M | ||||
| Total Asset | 6.1 M | ||||
| Retained Earnings | (34.35 M) | ||||
| Working Capital | 5.46 M | ||||
| Net Asset | 6.1 M |
About Bright Minds Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bright Minds Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bright Minds using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bright Minds Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Cost Of Revenue | 83.3 K | 43.2 K |
Currently Active Assets on Macroaxis
When determining whether Bright Minds Biosciences is a strong investment it is important to analyze Bright Minds' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bright Minds' future performance. For an informed investment choice regarding Bright Stock, refer to the following important reports:Check out Bright Minds Piotroski F Score and Bright Minds Altman Z Score analysis. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bright Minds. If investors know Bright will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bright Minds listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Bright Minds Biosciences is measured differently than its book value, which is the value of Bright that is recorded on the company's balance sheet. Investors also form their own opinion of Bright Minds' value that differs from its market value or its book value, called intrinsic value, which is Bright Minds' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bright Minds' market value can be influenced by many factors that don't directly affect Bright Minds' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bright Minds' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bright Minds is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bright Minds' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.